2008
A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients
Ceyhan M, Yıldırım I, Tekelı A, Yurdakok M, Us E, Altun B, Kutluk T, Cengiz AB, Gurbuz V, Barın C, Bagdat A, Cetınkaya D, Gur D, Tuncel O. A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients. American Journal Of Infection Control 2008, 36: 453-457. PMID: 18675153, DOI: 10.1016/j.ajic.2007.09.008.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsChryseobacteriumCluster AnalysisCross InfectionDisease OutbreaksDNA FingerprintingDNA, BacterialEnvironmental MicrobiologyFemaleFlavobacteriaceae InfectionsGenotypeHandHealth PersonnelHospital UnitsHumansInfantInfant, NewbornMaleMicrobial Sensitivity TestsRandom Amplified Polymorphic DNA TechniqueTurkeyConceptsNon-neonatal pediatric patientsHealth care workers' handsNeonatal intensive care unitTertiary health centerEnterobacterial repetitive intergenic consensus sequence polymerase chain reactionIntensive care unitInfection control measuresMeningosepticum infectionOlder patientsPediatric patientsPremature infantsCare unitPediatric wardPolymerase chain reactionHand culturesHealth centersIndex patientsNosocomial infectionsAmbu bagPatientsEtiologic agentAntimicrobial treatmentPowdered infant formulaOutbreak investigationInfant formula
2007
Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005
Ceyhan M, Yildirim I, Balmer P, Riley C, Laher G, Andrews N, Borrow R, Kurt N, Turgut M, Aydogan A, Ecevit C, Uysal G, Schultze V. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005. Vaccine 2007, 25: 7233-7237. PMID: 17707957, DOI: 10.1016/j.vaccine.2007.07.019.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsAgedAged, 80 and overAntibodies, BacterialChildChild, PreschoolFemaleHumansImmunoglobulin GInfantInfant, NewbornMaleMeningococcal InfectionsMicrobial ViabilityMiddle AgedNeisseria meningitidis, Serogroup ANeisseria meningitidis, Serogroup CNeisseria meningitidis, Serogroup W-135Neisseria meningitidis, Serogroup YSeroepidemiologic StudiesTurkeyConceptsSerum bactericidal antibodySerogroups ASerogroup CIgG concentrationsMeningococcal serogroup C diseaseSerum bactericidal antibody activityTurkish populationMeningococcal serogroup CMeningococcal vaccination programsSerogroup C diseaseAge-specific seroprevalenceSpecific IgG concentrationsRates of susceptibilityBactericidal antibody activityBaseline seroprevalenceSBA titersAntibody levelsProtective antibodiesIgG antibodiesVaccination programBactericidal antibodiesHealth centersC diseaseStudy populationC meningococci